Browse > Article

Construction of Improved Tetracycline-Inducible Expression System for the Effective Regulation of Transgene Expression  

Koo, Bon-Chul (Department of Physiology, Catholic University of Daegu School of Medicine)
Kwon, Mo-Sun (Department of Physiology, Catholic University of Daegu School of Medicine)
Kim, Teo-An (Department of Physiology, Catholic University of Daegu School of Medicine)
Publication Information
Reproductive and Developmental Biology / v.33, no.1, 2009 , pp. 63-69 More about this Journal
Abstract
In this study we tried to construct a more efficient tetracycline-inducible gene expression system by replacing previous key elements with more advance ones. At the beginning, we substituted PGK (phophoglycerate kinase) promoter for CMV (cytomegalovirus) promoter to control "$rtTA2^sM2$" which has been known for high induction efficiency in response to tetracycline. With this modification, expression of the EGFP marker gene under the induction condition was significantly increased. Next, we replaced "TRE" fragment with a modified version named "TRE-tighf" which has been reported to have higher affinity and specificity to the transactivator by minor base change of the "TRE" DNA fragment sequence. Use of "TRE-tighf" instead of "TRE" resulted in more than 10 fold increment in terms of induction efficiency and significant decrement of background expression in non-inducible condition. By combining PGK promoter and "TRE-tight" fragment, we could upgrade previous tetracycline-inducible system to show more stringent turn on/off gene switch ability and stronger expression of the gene of our interest. Use of this newly developed system must be very helpful to the studies of gene expression, especially to the transgenic animal study in which non-controllable constitutive expression of the transgene has been one of the urgent problems to be solved.
Keywords
$rtTA2^sM2$; PGK promoter; TRE-tight; EGFP; Induction efficiency;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ackland-Berglund CE, Leib DA (1995): Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques 18:196-200   PUBMED   ScienceOn
2 Backman CM, Zhang Y, Hoffer BJ, Tomac AC (2004): Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector. J Neurosci Methods 139:257-262   DOI   ScienceOn
3 Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H (1995): Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766- 1769   DOI   PUBMED
4 Klopotowska D, Strzadala L, Matuszyk J (2008): Inducibility of doxycycline-regulated gene in neural and neuroendocrine cells strongly depends on the appropriate choice of a tetracycline-responsive promoter. Neurochemistry International 52:221-229   DOI   ScienceOn
5 Lamartina S, Roscilli G, Rinaudo CD, Sporeno E, Silvi L, Hillen W, Bujard H, Cortese R, Ciliberto G, Toniatti C (2002): Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 13:199-210   DOI   ScienceOn
6 Rossi FMV, Blau HM (1998): Recent advances in inducible gene expression systems. Curr Opin Neurobiol 9:451-456   DOI   ScienceOn
7 Zufferey R, Donello JE, Trono D, Hope TJ (1999): Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892   PUBMED   ScienceOn
8 Koo BC, Kwon MS, Kim T (2005): Regulation of GFP expression using the tetracycline inducible retroviral vector system. Reprod Dev Biol 29:57-62   과학기술학회마을   ScienceOn
9 Ryding ADS, Sharp MGF, Mullins JJ (2001): Conditional transgenic technologies. J Endocrinol 171:1–14.   DOI   PUBMED
10 Bohl D, Salvetti A, Moullier P, Heard JM (1998): Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92: 1512-1517   PUBMED   ScienceOn
11 Strathdee CA, McLeod MR, Hall JR (1999): Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 229:21-29   DOI   PUBMED   ScienceOn
12 Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000): Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963–7968   DOI   PUBMED   ScienceOn
13 Bohl D, Naffakh N, Heard JM (1997): Long-term control of erythropoietin secretion by doxycycline in mice with engineered primary myoblast. Nature Med 3:299-305   DOI   ScienceOn
14 Watsuji T, Okamoto Y, Emi N, Katsuoka Y, Hagiwara M (1997): Controlled gene expression with a reverse tetracycline-regulated retrovirus vector (RTRV) system. Biochem Biophys Res Commun 234:769-773   DOI   ScienceOn
15 Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H, Bujard H (1996): Doxycycline- mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938   DOI   ScienceOn
16 Mansuy IM, Bujard H (2000): Tetracycline-regulated gene expression in the brain. Curr Opin Neurobiol 10: 593-596   DOI   ScienceOn
17 Gossen M, Bujard H (1992): Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551   DOI   PUBMED   ScienceOn
18 Lamartina S, Silvi L, Roscilli G, Casimiro D, Simon AJ, Davis M-E, Shiver JW, Rinaudo CD, Zampaglione I, Fattori E, Colloca S, Paz OG, Laufer R, Bujard H. Cortese R, Ciliberto G, Toniatti C (2003): Construction of an $rtTA2^{s}$-$M2/tTS^{kid}$-based transcription regualtory switch that displays no basal activity, good inducibility and high responsiveness to doxycycline in mice and non-human primates. Mol Ther 7:271-280   DOI   ScienceOn
19 Fitzsimons HL, McKenzie JM, During MJ (2001): Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 8:1675–1681   DOI   PUBMED   ScienceOn
20 Mayford M, Bach ME, Huang Y.-Y, Wang L, Hawkins RD, Kandel ER (1996): Control of mamary formation through regulated-expression of a CaMK transgene. Science 274:1678-1683   DOI   PUBMED   ScienceOn
21 Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA (2002): Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Cell Develop Biol 13:121-128   DOI   ScienceOn
22 Smith-Arica JR, Morelli AE, Larregina AT, Smith J, Lowenstein PR, Castro MG (2000): Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encode combined transcriptional targeting and inducible transgene expression. Mol Ther 2:579–587   DOI   ScienceOn
23 Sadowski I, Ma J, Triezenberg S, Ptashne M (1988): GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564   DOI   ScienceOn
24 Yarranton GT (1992): Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 3:506-511   DOI   PUBMED   ScienceOn
25 Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT (2004): Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817-828   DOI   ScienceOn
26 Sipo I, Picó AH, Wang X, Eberle J, Petersen I, Weger S, Poller W, Fechner H (2006): An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy. J Mol Med 84:215-225   DOI   ScienceOn
27 Salucci V, Scarito A, Aurisicchio L, Lamartina S, Nicolaus G, Giampaoli S, Gonzalez-Paz O, Toniatti C, Bujard H, Hillen W, Ciliberto G, Palombo F (2002): Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther 9:1415-21   DOI   ScienceOn